Drug Trial Radar · NCT07057037
Phase 3 Study of the Efficacy and Safety of MR Arthrography Using the NEMO-103 Injection in Patients With Known or Suspected Shoulder Joint Diseases
Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
85
Actual
Start
Sep 23, 2025
Primary completion
Apr 14, 2026
Study completion Sep 18, 2026
Sponsor
- Lead sponsor
- Inventera Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 9, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- No
- Who can join
- All sexes, from 19 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this Phase 3 clinical trial is to evaluate whether MR arthrography enhanced with NEMO-103 injection (NEMO-103 Inj.) provides superior diagnostic imaging quality compared to unenhanced MRI in patients with known or suspected shoulder joint disorders, such as rotator cuff tendon tears, labral tears, and articular cartilage injuries. ⦁ The primary objective is to determine whether NEMO-103 Inj.-enhanced MR arthrography offers improved imaging quality in terms of joint distension, contrast resolution, and image sharpness compared to standard unenhanced MRI. Participation Details: * Each participant will undergo two MRI scans: one unenhanced and one enhanced with NEMO-103 Inj. * NEMO-103 Inj. will be administered once, during the second study visit. * Participants will attend a total of three site visits.
Conditions
- Rotator Cuff Tear
- Labral Tear
- Rotator Cuff Tendinosis
- Rotator Cuff Tendonitis
- Articular Cartilage Injury
- Glenohumeral Ligament
- Long Head Biceps Tendon Tear
- Adhesive Capsulitis
Interventions
NEMO-103 InjectionDrug
15mL(at least 12mL), solution for Intravenous injection, single dose
Primary outcomes
What the sponsor says the trial is designed to measure.
- Qualitative Image Quality Metrics (Distension, Contrast, Sharpness) to Be Evaluated by Independent Central ReadersTime frame: 1day procedure
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
Seoul National University Hospital
Seoul, Seoul Teugbyeolsi, South Korea
Yonsei University Health System, Severance Hospital
Seoul, Seoul Teugbyeolsi, South Korea
Konkuk University Medical Center
Seoul, Seoul Teugbyeolsi, South Korea
Gangnam Severance Hospital
Seoul, Seoul Teugbyeolsi, South Korea
The Catholic University of Korea Seoul ST. Mary's Hospital
Seoul, Seoul Teugbyeolsi, South Korea
Korea University Guro Hospital
Seoul, Seoul Teugbyeolsi, South Korea
Asan Medical Center
Seoul, Seoul Teugbyeolsi, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.